BPC-157 vs Epitalon
Compare the research profiles of BPC-157 and Epitalon. Read the individual guides for evidence and limitations.
How to interpret this comparison
This page summarizes database profiles and has not yet received a study-by-study editorial review. These compounds are filed under different research categories, so a direct treatment comparison may not answer a meaningful clinical question. Use the linked guides and primary sources to evaluate a specific claim.
How to read peptide studiesBPC-157
Body Protection Compound-157
healing
Preclinical (Animal Studies)
not-approved
Epitalon
Epitalon (Epithalon)
anti-aging
Preclinical
not-approved
Detailed Comparison
| Aspect | BPC-157 | Epitalon |
|---|---|---|
| Overview | A synthetic peptide consisting of 15 amino acids, derived from a protective protein found in human gastric juice. Popular in biohacking communities for purported healing properties.... | A synthetic tetrapeptide studied for telomerase activation and potential anti-aging effects. Developed by Russian scientist Vladimir Khavinson. Popular in longevity circles.... |
| Research topics (not established benefits) |
|
|
| Side Effects |
|
|
| Mechanism | Believed to work through multiple mechanisms including: stimulating angiogenesis (new blood vessel formation), modulating nitric oxide synthesis, prom... | Believed to activate telomerase, the enzyme that maintains telomere length. Telomere shortening is associated with aging, so maintaining length could ... |
Frequently Asked Questions
Does a comparison establish which treatment is better?
Only appropriately designed evidence for the same clinical question can support that conclusion. Database categories and mechanisms alone cannot rank treatments.
Does this page establish that these compounds can be combined?
No. This page does not assess interactions or the benefit and safety of combined use. Individual studies cannot establish the effects of a combination.